Featured News

2023 promises to be a year full of robust research, advocacy, and education efforts on behalf of our patient community.

The American College of Gastroenterology has updated its guidelines for the diagnosis and management of celiac disease, bringing current the recommendations outlined in 2013.

Consider joining the CeDar Rose Study, a remote celiac disease study that will monitor individual gluten tolerance.

The Celiac Disease Foundation is pleased to announce it will provide patient recruitment and eligibility screening for Anokion’s phase 1b/2 clinical trial for KAN-101.

The Celiac Disease Foundation announces its newest appointee, William Thurston, to its Board of Directors.

Consider joining the LILY Study, a phase 1 clinical trial for people with celiac disease investigating DONQ52, a new potential celiac disease treatment.

iCureCeliac® is the Foundation’s patient-powered tool that is the single best resource for celiac disease researchers around the world helping to accelerate the search for treatments and a cure.

Curing Celiac: A Short Story, a new film by Hayley Repton, encourages patients to join the iCureCeliac® patient registry, the single best patient-centered resource for celiac disease researchers in the world.

We are excited to be an Official Charity Partner in the 2022 TCS NYC Marathon!

The FDA released the long-awaited draft guidance, “Celiac Disease: Developing Drugs for Adjunctive Treatment to a Gluten-Free Diet."